BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1220 related articles for article (PubMed ID: 9042204)

  • 1. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
    Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
    Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1759-68. PubMed ID: 10928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.
    Bodey B; Kaiser HE; Goldfarb RH
    Anticancer Res; 1996; 16(1):517-31. PubMed ID: 8615665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
    Bodey B; Bodey B; Siegel SE
    Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
    Lyle S; Salhany KE; Elder DE
    Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
    Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
    Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma.
    Ksander BR; Rubsamen PE; Olsen KR; Cousins SW; Streilein JW
    Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3198-208. PubMed ID: 1748551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function and prognostic significance of immune cells infiltrating human tumors].
    Ladányi A
    Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients.
    Maccalli C; Nonaka D; Piris A; Pende D; Rivoltini L; Castelli C; Parmiani G
    Clin Cancer Res; 2007 Dec; 13(24):7459-68. PubMed ID: 18094430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
    Bodey B; Bodey B; Kaiser HE
    Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood.
    Burns GF; Good MF; Riglar C; Bartlett PF; Crapper RM; Mackay IR
    Clin Exp Immunol; 1984 Aug; 57(2):487-94. PubMed ID: 6331928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.
    Salio M; Cella M; Vermi W; Facchetti F; Palmowski MJ; Smith CL; Shepherd D; Colonna M; Cerundolo V
    Eur J Immunol; 2003 Apr; 33(4):1052-62. PubMed ID: 12672071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.